Form 4: Performant Healthcare Director Receives Equity Award

Performant Healthcare Inc. Director Shantanu Agrawal received an award of 35,616 restricted stock units, aligning his interests with shareholder value.

Summary

• Shantanu Agrawal, a Director of Performant Healthcare Inc. (PHLT), was granted 35,616 Restricted Stock Units (RSUs).
• The transaction date for this award was July 28, 2025.
• Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock.
• The units were awarded at no cost to the reporting person.
• The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control, as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan.
• The restricted stock units may be settled only for shares of common stock on a one-for-one basis.
• Following this transaction, Shantanu Agrawal beneficially owns 35,616 Restricted Stock Units.

Sentiment

Score: 7

Explanation: The award of restricted stock units to a director is a positive sign of aligning management interests with shareholder value, though it is a routine compensation event and not indicative of significant operational or financial changes.

Positives

• The award of restricted stock units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This type of equity compensation is a common practice to incentivize long-term commitment and performance from key personnel.

Future Outlook

The Restricted Stock Units are set to vest fully on the earlier of the company's 2026 annual meeting of stockholders or a Change in Control, indicating a future milestone for the director's equity compensation.

Industry Context

The granting of restricted stock units to directors is a standard practice across various industries, particularly in publicly traded companies, to attract and retain talent while aligning their financial incentives with the company's long-term success and shareholder returns.

Comparison to Industry Standards

• The award of restricted stock units as a form of director compensation is consistent with common practices observed in comparable healthcare services companies and other publicly traded entities.
• Many companies, such as Optum (a UnitedHealth Group company) or Change Healthcare, utilize similar equity-based incentives for their non-executive directors to foster long-term commitment and align interests with shareholders.

Corporate Governance

Related Party Transactions

• The transaction involves the company granting equity to a director, which constitutes a related party transaction as the director is considered an insider.

Stakeholder Impact

• Shareholders: The equity award aligns the director's financial interests with the company's stock performance, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The Restricted Stock Units will vest with respect to 100% of the shares on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation award to a director, which aligns their interests with shareholders but does not provide new fundamental information or significant operational updates to alter an investment thesis. Therefore, a 'hold' recommendation is appropriate as this event alone does not warrant a change in investment strategy.

Keywords

Performant Healthcare Inc., PHLT, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Transaction, Form 4, Corporate Governance